Key facts
- This page summarizes Robert Thomas Freeman's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2022, 21:21.
Robert Thomas Freeman - 01 Aug 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ALHC
- Reported as of
- 01 Aug 2022
- Net transaction value
- -$348,019
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2022, 21:21:56 UTC
- Prior SEC filing
- 07 Jul 2022
- Next SEC filing
- 09 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard A. Cross, as Attorney-in-Fact, for Robert Thomas Freeman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Thomas Freeman filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 02 Aug 2022.
Change
- Previous filing in this sequence was filed on 07 Jul 2022.
- Current net transaction value: -$348,019.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $348,019
- Shares
- -24,000
- Change %
- -3.5%
- Price
- $14.50
- Shares after
- 659,939
- Date
- 01 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1, F2
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 412,269
- Date
- 01 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Footnote F2
Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.